Alert button

HEROHE Challenge: assessing HER2 status in breast cancer without immunohistochemistry or in situ hybridization

Nov 08, 2021
Eduardo Conde-Sousa, João Vale, Ming Feng, Kele Xu, Yin Wang, Vincenzo Della Mea, David La Barbera, Ehsan Montahaei, Mahdieh Soleymani Baghshah, Andreas Turzynski, Jacob Gildenblat, Eldad Klaiman, Yiyu Hong, Guilherme Aresta, Teresa Araújo, Paulo Aguiar, Catarina Eloy, António Polónia

Figure 1 for HEROHE Challenge: assessing HER2 status in breast cancer without immunohistochemistry or in situ hybridization
Figure 2 for HEROHE Challenge: assessing HER2 status in breast cancer without immunohistochemistry or in situ hybridization
Figure 3 for HEROHE Challenge: assessing HER2 status in breast cancer without immunohistochemistry or in situ hybridization
Figure 4 for HEROHE Challenge: assessing HER2 status in breast cancer without immunohistochemistry or in situ hybridization

Share this with someone who'll enjoy it:

View paper onarxiv icon

Share this with someone who'll enjoy it: